SCHEMBL4584356

SCHEMBL4584356

Cc1ccccc1C(=O)N1CCN(c2ccc(Nc3nccc(-c4ccc(CC(N)=O)cc4)n3)cc2)CC1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
JAK2 O60674 13/20 0.52
MAPT P10636 2/20 0.49
USP2 O75604 1/20 0.49
TSHR P16473 1/20 0.49
CASP1 P29466 1/20 0.49
CASP7 P55210 1/20 0.49
HSD17B10 Q99714 1/20 0.49
JAK3 P52333 4/20 0.49
LMNA P02545 2/20 0.49
HTT P42858 2/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
AURKA O14965 2/20 0.48
CDK4 P11802 2/20 0.48
CDK2 P24941 2/20 0.48
CDK7 P50613 2/20 0.48
CDK9 P50750 2/20 0.48
AURKB Q96GD4 2/20 0.48
HDAC1 Q13547 1/20 0.48
HDAC6 Q9UBN7 1/20 0.48
CDK1 P06493 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4380141 0.86 JAK2 (0.70) JAK2MAPTUSP2TSHRCASP1
SCHEMBL4381182 0.83 JAK2 (0.60) JAK2JAK3AURKACDK4CDK2
SCHEMBL4584094 0.83 JAK2 (0.59) JAK2JAK3CDK2CDK9HDAC1
SCHEMBL4602091 0.82 GSK3B (0.57) JAK2JAK3HDAC1HDAC6
SCHEMBL4583408 0.79 JAK2 (0.57) JAK2JAK3HDAC1HDAC6
SCHEMBL4603072 0.79 JAK2 (0.54) JAK2JAK3AURKACDK2CDK7
SCHEMBL27739754 0.79 JAK2 (0.66) JAK2JAK3HDAC1HDAC6
SCHEMBL4377340 0.79 JAK2 (0.72) JAK2JAK3CDK2CDK7CDK9
SCHEMBL14021615 0.78 JAK2 (0.57) JAK2MAPTJAK3HTTCDK2
SCHEMBL4382992 0.78 JAK2 (0.70) JAK2JAK3HDAC1HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008124085-A2 METHODS OF USING COMBINATIONS OF MEK AND JAK-2 INHIBITORS EXELIXIS, INC. (US) 2008-10-16 WO claimed